These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24027727)

  • 1. Granulocyte Colony-stimulating Factor for Preterms with Sepsis and Neutropenia: A Randomized Controlled Trial.
    Chaudhuri J; Mitra S; Mukhopadhyay D; Chakraborty S; Chatterjee S
    J Clin Neonatol; 2012 Oct; 1(4):202-6. PubMed ID: 24027727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
    Gathwala G; Walia M; Bala H; Singh S
    J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blinded, placebo-controlled trial of early administration of recombinant human granulocyte colony-stimulating factor to non-neutropenic preterm newborns between 33 and 36 weeks with presumed sepsis.
    Kücüködük S; Sezer T; Yildiran A; Albayrak D
    Scand J Infect Dis; 2002; 34(12):893-7. PubMed ID: 12587621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-colony stimulating factor in neonatal sepsis with leukopenia: A prospective cohort study.
    Ahmad AM; Ahmed Z; Khushdil A; Waqar T
    J Pak Med Assoc; 2018 Nov; 68(11):1613-1617. PubMed ID: 30410138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of granulocyte colony stimulating factor administration on preterm infant with neutropenia and clinical sepsis: a randomized clinical trial.
    Borjianyazdi L; Froomandi M; Noori Shadkam M; Hashemi A; Fallah R
    Iran J Ped Hematol Oncol; 2013; 3(2):64-8. PubMed ID: 24575272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
    Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
    Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
    Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
    Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors for neutropenia of late newborns].
    Li L; Yang B; Gao XY; Ren Y; Su M; Yang CY; Huang D; Wang HY
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Apr; 23(4):375-380. PubMed ID: 33840410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
    Harker LA; Marzec UM; Kelly AB; Cheung E; Tomer A; Nichol JL; Hanson SR; Stead RB
    Blood; 1997 Jan; 89(1):155-65. PubMed ID: 8978288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
    Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
    Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the treatment of neonates in presumed sepsis with neutropenia.
    Khan TH; Shahidullah M; Mannan MA; Nahar N
    Mymensingh Med J; 2012 Jul; 21(3):469-74. PubMed ID: 22828545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia.
    Bedford Russell AR; Emmerson AJ; Wilkinson N; Chant T; Sweet DG; Halliday HL; Holland B; Davies EG
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F172-6. PubMed ID: 11320043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
    Carr R; Modi N; Doré CJ; El-Rifai R; Lindo D
    Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of neutropenia and granulocyte colony stimulating factor-induced neutrophilia on blood-brain barrier permeability and brain edema after traumatic brain injury in rats.
    Whalen MJ; Carlos TM; Wisniewski SR; Clark RS; Mellick JA; Marion DW; Kochanek PM
    Crit Care Med; 2000 Nov; 28(11):3710-7. PubMed ID: 11098978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessing the efficacy of the recombinant human granulocyte colony-stimulating factor "rhG-CSF" in the treatment of early neonatal sepsis in premature neonates].
    Miura E; Procianoy RS; Bittar C; Miura CS; Melo C; Miura MS
    J Pediatr (Rio J); 2000; 76(3):193-9. PubMed ID: 14647669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
    Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
    Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
    Carr R; Brocklehurst P; Doré CJ; Modi N
    Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.